Focused Wealth Management, Inc - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 221 filers reported holding IMMUNOGEN INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$1,587
-15.9%
1000.0%0.00%
Q2 2023$1,887
+391.4%
1000.0%0.00%
Q1 2023$384
-22.6%
1000.0%0.00%
Q4 2022$4961000.0%0.00%
Q3 2022$01000.0%0.00%
Q2 2022$0
-100.0%
100
-20.0%
0.00%
Q1 2022$1,0000.0%1250.0%0.00%
Q4 2021$1,0000.0%1250.0%0.00%
Q3 2021$1,0000.0%125
+25.0%
0.00%
Q2 2021$1,0000.0%1000.0%0.00%
Q1 2021$1,0000.0%1000.0%0.00%
Q4 2020$1,0001000.0%0.00%
Q3 2020$01000.0%0.00%
Q2 2020$01000.0%0.00%
Q1 2020$0
-100.0%
1000.0%0.00%
Q4 2019$1,0001000.0%0.00%
Q3 2019$01000.0%0.00%
Q2 2019$01000.0%0.00%
Q1 2019$01000.0%0.00%
Q4 2018$0
-100.0%
1000.0%0.00%
Q3 2018$1,0000.0%1000.0%0.00%
Q2 2018$1,0000.0%1000.0%0.00%
Q1 2018$1,0000.0%1000.0%0.00%
Q4 2017$1,0000.0%1000.0%0.00%
Q3 2017$1,0000.0%1000.0%0.00%
Q2 2017$1,0001000.0%0.00%
Q1 2017$01000.0%0.00%
Q4 2016$01000.0%0.00%
Q3 2016$01000.0%0.00%
Q2 2016$0
-100.0%
1000.0%0.00%
-100.0%
Q1 2016$1,0000.0%1000.0%0.00%0.0%
Q4 2015$1,0000.0%1000.0%0.00%0.0%
Q3 2015$1,0000.0%1000.0%0.00%0.0%
Q2 2015$1,0000.0%1000.0%0.00%0.0%
Q1 2015$1,0000.0%1000.0%0.00%0.0%
Q4 2014$1,0000.0%1000.0%0.00%0.0%
Q3 2014$1,0000.0%1000.0%0.00%0.0%
Q2 2014$1,0000.0%1000.0%0.00%0.0%
Q1 2014$1,0000.0%1000.0%0.00%0.0%
Q4 2013$1,000
-50.0%
1000.0%0.00%
-50.0%
Q3 2013$2,0001000.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 10,906,962$69,914,0003.04%
Fernwood Investment Management, LLC 224,500$1,439,0000.77%
Telemetry Investments, L.L.C. 272,000$1,744,0000.66%
Schonfeld Strategic Advisors LLC 865,356$5,547,0000.45%
Virtus ETF Advisers LLC 53,977$346,0000.43%
Endurant Capital Management LP 210,800$1,351,0000.41%
SPHERA FUNDS MANAGEMENT LTD. 500,000$3,205,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$726,0000.37%
Orbimed Advisors 2,834,126$18,167,0000.23%
PINNACLE ASSOCIATES LTD 1,322,231$8,476,0000.16%
View complete list of IMMUNOGEN INC shareholders